Global Female Contraceptive Market 2016-2020
SKU ID :TNV-10288411 | Published Date: 27-Oct-2016 | No. of pages: 78Description
TOC
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Market landscape
• Market overview
• Five forces analysis
PART 06: Geographical segmentation
• Global female contraceptive market by geography
• Female contraceptive market in Americas
• Female contraceptive market in EMEA
• Female contraceptive market in APAC
PART 07: Product segmentation
• Global female contraceptive market by product segmentation
• Global female contraceptive market by devices
• Global IUD market
• Global sterilization market
• Global subdermal contraceptive implant market
• Global vaginal ring market
• Global female condom market
• Global non-surgical permanent contraception market
• Global contraceptive diaphragm market
• Global contraceptive sponge market
• Global female contraceptive drug market
• Global birth control pill market
• Global emergency pill market
PART 08: Market drivers
PART 09: Impact of drivers
PART 10: Market challenges
PART 11: Impact of drivers and challenges
PART 12: Market trends
PART 13: Vendor landscape
• Competitive scenario
PART 14: Key vendor analysis
• Allergan
• Merck Millipore
• Pfizer
• Teva Pharmaceuticals
• Other prominent vendors
PART 15: Appendix
• List of abbreviations
PART 16: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Global female contraceptive market: An overview
Exhibit 03: Advantages and disadvantages of different types of contraceptives
Exhibit 04: Effectiveness of female contraceptives
Exhibit 05: Global female contraceptive market ($ billions)
Exhibit 06: Impact factors of the global female contraceptive market
Exhibit 07: Investment opportunity in global female contraceptive market
Exhibit 08: Effectiveness of family planning methods
Exhibit 09: Top-ranked women health issues 2015
Exhibit 10: Five forces analysis
Exhibit 11: Global female contraceptive market by geography 2015-2020 (% share)
Exhibit 12: Global female contraceptive market by geography 2015-2020
Exhibit 13: Female contraceptive market in the Americas 2015-2020 ($ billions)
Exhibit 14: Percentage of women aged 15-44 using modern contraceptives in US 2015
Exhibit 15: Key leading countries
Exhibit 16: Female contraceptive market in EMEA 2015-2020 ($ billions)
Exhibit 17: Key leading countries
Exhibit 18: Female contraceptive market in APAC 2015-2020 ($ billions)
Exhibit 19: Key leading countries
Exhibit 20: Global female contraceptive market by product segmentation 2015 (% share)
Exhibit 21: Opportunity analysis for global female contraceptive market by product segmentation
Exhibit 22: Global female contraceptive device market 2015-2020 ($ billions)
Exhibit 23: Global female contraceptive device market by type 2015-2020
Exhibit 24: Global IUD market 2015-2020 ($ millions)
Exhibit 25: Global sterilization market 2015-2020 ($ millions)
Exhibit 26: Global subdermal contraceptive implant market 2015-2020 ($ millions)
Exhibit 27: Global vaginal ring market 2015-2020 ($ millions)
Exhibit 28: Global female condom market 2015-2020 ($ millions)
Exhibit 29: Global non-surgical permanent contraception market 2015-2020 ($ millions)
Exhibit 30: Global contraceptive diaphragm market 2015-2020 ($ millions)
Exhibit 31: Global contraceptive sponge market 2015-2020 ($ millions)
Exhibit 32: Global female contraceptive drug market 2015-2020 ($ billions)
Exhibit 33: Global female contraceptive market by type 2015 and 2020
Exhibit 34: Global birth control pill market 2015-2020 ($ millions)
Exhibit 35: Global emergency pill market 2015-2020 ($ millions)
Exhibit 36: Key leading countries in emergency pills
Exhibit 37: Unplanned pregnancies by region (millions)
Exhibit 38: Impact of drivers
Exhibit 39: Impact of drivers and challenges
Exhibit 40: Non-contraceptive health benefits
Exhibit 41: Population of women using birth pills for non-contraceptive reasons
Exhibit 42: Competitive parameters in global female contraceptive market
Exhibit 43: Strategic success factor of companies
Exhibit 44: Key takeaways
Exhibit 45: Key takeaways
Exhibit 46: Pfizer: Key takeaways
Tables & Figures
Companies
Allergan, Merck Millipore, Pfizer, Teva, Afaxys, Agile Therapeutics, Ansell, Bayer Pharma, Caya, Ferring Pharmaceuticals, Female Health, Fuji Latex, HLL Lifecare, Janssen Pharmaceuticals, Lipocine, Lupin Pharmaceuticals, Mayer Laboratories, Okamoto Industries, Reckitt Benckiser, Syzygy Healthcare, V-Care Pharma
- PRICE
-
$2500$4000